Clinical Trial Update: Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of GSK933776 in adults with geographic atrophy due to age-related macular degeneration has completed, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• GSK933776

Snippet

Sponsor: GlaxoSmithKline | Conditions: Atrophy, Geographic | Phase 2 | Status: COMPLETED | Results posted: 2017-05-05